MHP
CEMI

Manatuck Hill Partners’s Chembio diagnostics, Inc. CEMI Stock Holding History

Manatuck Hill Partners’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-65,000
Closed -$333K – 104
2020
Q1 		$333K Buy
+65,000
New +$263K 0.31% 57

Other funds holding CEMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manatuck Hill Partners's CEMI Position: Q2 2020 in Review

Manatuck Hill Partners sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2020, closing a stake of 65,000 shares — an estimated $333K sold.

Manatuck Hill Partners first reported a position in CEMI in Q1 2020 and held it in 1 quarter. The position peaked at $333K in Q1 2020. 76 funds tracked by Wall St. Rank hold CEMI as of Q2 2020.

  • Manatuck Hill Partners reported no remaining Chembio diagnostics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Manatuck Hill Partners sold 65,000 Chembio diagnostics, Inc. shares in Q2 2020, an estimated $333K.
  • Manatuck Hill Partners first reported a position in Chembio diagnostics, Inc. in Q1 2020 and held it in 1 quarter.
  • Manatuck Hill Partners's Chembio diagnostics, Inc. position peaked at $333K in Q1 2020.
  • 76 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2020.

Based on Manatuck Hill Partners's 13F filing for Q2 2020, filed 14 Aug 2020.